Novus Biologicals™ Bcl-10 Antibody Blocking Peptide

Catalog No.	Quantity
NBP176882E	0.05 mg

Catalog No. NBP176882E Supplier Novus Biologicals™ Supplier No. NBP176882PEP

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 15 amino amino terminus of human BCL-10. Source: Synthetic (Accession #: AF134395) The Bcl-10 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

• Gene ID (Entrez): 8915
• Species: Human
• Content And Storage: Store at -20 C. Avoid freeze-thaw cycles.
• Formulation: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• For Use With (Application): This Peptide is Useful as a Blocking Peptide for NBP1-76882. For Further Blocking Peptide Related Protocol, Click Here .
• Gene Alias: B-cell CLL/lymphoma 10 CIPERCLAPB-cell lymphoma/leukemia 10, Bcl-10, CARD-containing apoptotic signaling protein, CARD-containing molecule enhancing NF-kappa-B, CARD-containing proapoptotic protein, CARD-like apoptotic protein, CARMEN, caspase-recruiting domain-containing protein, cCARMEN, c-E10bcl-10, CED-3/ICH-1 prodomain homologous E10-like regulator, Cellular homolog of vCARMEN, cellular-E10, hCLAP, Mammalian CARD-containing adapter molecule E10, mE10CARD containing molecule enhancing NF-kB
• Gene Symbol: BCL10
• Product Type: Bcl-10
• Quantity: 0.05 mg
• Regulatory Status: RUO - research use only
• Source: Synthetic
• Termination: 15 amino amino terminus of human BCL-10